TB-500 Vials (5 mg each): 8 weeks 3 vials 12 weeks 4 vials 16 weeks 5 vials BPC-157 Vials (5 mg each): 8 weeks 5 vials 12 weeks 7 vials 16 weeks 8 vials Insulin Syringes (U-100): 8 weeks: 68 syringes (TB-500: 12 + BPC-157: 56) 12 weeks: 100 syringes (TB-500: 16 + BPC-157: 84) 16 weeks: 132 syringes (TB-500: 20 + BPC-157: 112) Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution
Clinical manifestation improved in 8 of 12 subjects of which 4 had a complete response, in absence of relevant toxicities ( These positive findings were further supported by a multicenter clinical study involving 40 patients with SR-aGVHD
Jin JK, Blackwood EA, Azizi K, Thuerauf DJ, Fahem AG, Hofmann C, Kaufman RJ, Doroudgar S, Glembotski CC
Adjusted EBITDA was $54 million for the fourth quarter as compared to $21 million during the same period a year ago
Tirzepatide, sold as Mounjaro and Zepbound, works similarly but also targets another hormone, GIP, which may further enhance weight loss